Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment
Clinical trial NCT04647526 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04647526
- Sponsor
- POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2023-11-01
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.